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Abstract
Schistosomiasis continues to be the leading cause of morbidity and mortality among the neglected tropical diseases. Apart from
the high cost of chemotherapy, concerns over drug resistance and tolerance have been raised in the past decade. The aim of the
study was to evaluate the anticercarial activity of extracts and compounds from the stem bark of Holarrhena floribunda on cercaria
of Schistosoma haematobium. Hydroethanolic and alkaloidal extracts from the stem bark of H. floribunda were tested on cercaria
at concentrations between 500.00 and 15.625 µg/mL for 180 minutes and assessing the percentage viability at time intervals of
0, 15, 30, 60, 120 and 180 minutes. Praziquantel, used as reference drug, and the isolated compounds were tested at similar
concentrations. The cercaria mortalities and IC50 of extracts and compounds were estimated after 30 minutes of incubation. The
70 %v/v ethanol extract showed the highest activity (IC50=20.09±1.11 µg/mL) with praziquantel giving IC50 of 695.50±1.12. The
alkaloids holonamine, holadienine and conessine, isolated from the stem bark, showed considerable cercaricidal activity with the
latter recording an IC50 of 33.28±1.04. The study gives first-hand knowledge of the anti-cercarial activity of H. floribunda and its
steroidal alkaloids. This gives credence to the traditional uses of the plant as an anti-parasitic agent.
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Introduction
Among the neglected tropical diseases, Schistosomiasis ranks
second in terms of the number of deaths it causes. [1] It is
caused by the infective stage (cercariae) of Schistosoma species.
In Africa, the species S. mansoni, S. haematobium, S. guineen-
sis and S. intercalatum are mostly implicated in the disease al-
though S. japonicum and S. mekongi also cause schistosomia-
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sis in man. [1] In 2001, it was estimated that S. haematobium
and S. mansoni accounted for 166 million cases of schistosomi-
asis. [2] Death from S. mansoni and S. haematobium infection
is estimated to be around 130,000 to 150,000 annually through
complications such as kidney failure and portal hypertension. [1]
In Ghana, Aryeetey et al. [3] estimated a prevalence of
54.8%-60% after sampling 2,562 members in eight villages in
the Ga West and Akuapem North municipality, endemic to S.
haematobium. However, recent studies done in villages along
the Tono irrigation canal in the Upper East Region of Ghana,
estimates a prevalence of 33.2% and 19.8% respectively for S.
haematobium and S. mansoni, with a combined prevalence of
47.7%. [4]
With the wide geographical distribution of schistosomi-
asis, it has become increasingly difficult to treat. [1] Until
1972, the WHO had not accepted any drug for population-based
chemotherapy although some drugs were in use. [5] Praziquantel
(PZQ) remains the drug of choice although there have been fears
of resistance as well as its inability to prevent reinfection and
kill juvenile schistosomes. Artemether (ART) is known to be
effective in killing juvenile stages of schistosomes. In endemic
countries like Ghana, with high incidence of malaria, other alter-
natives to ART is needed, as resistance of plasmodium parasites
to ART can further dampen treatment options for malaria. [6]
It is therefore not surprising that combination therapy of PZQ
and ART as a means of treatment was discontinued. There is the
need to look for alternate effective, cheaper and more available
sources of drugs to delay tolerance and resistance and to serve
as a source of novel agents for the treatment of schistosomiasis
in endemic regions of Africa and Ghana where access to qual-
ity health care is a challenge. A number of novel drugs have
found their source from plants. Investigation of the efficacy of
medicinal plants used in traditional medicine for the treatment of
diseases led to the discovery of a number of drugs used in con-
ventional medicine. Holarrhena floribunda has been reported
to have considerable therapeutic properties. [7] The plant is
native to West Africa and is known in Ghana as ‘osese’ (among
the Akans). It is an antifungal, antibacterial and antidiabetic
agent [8–10] and also finds use traditionally for the treatment
and management of malaria, fever and female sterility [8–10].
Studies have shown the leaf and stem bark extracts of Holar-
rhena floribunda and its alkaloid fractions to show significant in
vitro activity against bloodstream forms of Trypanosoma brucei
rhodesiense. [11] Yemoa et al. [12] demonstrated the antimy-
cobacterium activity of extracts and alkaloids from the aerial
part of H. floribunda against Mycobacterium ulcerans. Thus, the
potential of H. floribunda in the management of the neglected
tropical diseases is not in doubt. Therefore, in this study, H.
floribunda extracts fractions and isolated compounds were eval-
uated against aquatic forms of the parasite (cercaria from Buli-
nus species) as a means of paving the way for the development
of cercaricidal agents for water treatment in endemic areas.
Materials and methods
Solvents and chemicals
The solvents and reagents were of analytical grade. Ethanol,
petroleum ether, ethyl acetate, methanol, acetic acid, concen-
trated ammonia, dimethyl sulfoxide (DMSO) were obtained
from Sigma-Aldrich company (Darmstadt, Germany), tween
80 (Nacalai Tesque (Kyoto, Japan), desk lamp, sterile petri
dish, pyrex beakers, 24-microtiter well plate, conditioned water
(Lab Aid, Accra, Ghana), Leica microscope, counting chamber
(GmbH, Wetzlar, Germany). Silica gel 60 (70-230 Mesh) and
precoated silica gel TLC plate F254 obtained from Merck Milli-
pore (United Kingdom).
Equipment
These include rotary evaporator (Buchi, Switzerland), LC-MS
(LTQ Orbitrap spectrometer, Thermofisher, USA) coupled to
Agilent 1200 (Santa Clara, USA) HPLC, NMR techniques were
performed on Bruker Avance DRX-500 (500 MHz), Varian
Unity Inova (500 MHz), Inova spectrometer (600 MHz) or
AVANCE III HDX (Bruker BioSpin GmbH; 700 MHz), Jenway
UV-VIS spectrophotometer, Heraeus Biofuge Primo Centrifuge,
Bruker Fourier transform infrared (FT-IR) spectrometer, Stuart
SMP10 digital melting point apparatus (Cole-Palmer, Stafford-
shire, UK).
Plant collection and identification
The stem bark of H. floribunda was harvested from Axim
(4◦52’19.3”N, 2◦14’32.3”W) in the Western region of Ghana in
July 2017. It was identified and authenticated by Mr Emmanuel
Agyarkwah of the Herbarium section of the University of Cape
Coast and given a voucher number 1761.
Material processing and extraction
The stem bark of H. floribunda was rid of extraneous matter and
dried at room temperature (25 -27 ºC) for one week. It was pul-
verized and 1500 g of the powdered bark extracted with 5 L of
70% v/v ethanol by cold maceration. It was then filtered with
Watman number 3 filter paper and concentrated using a rotary
evaporator. The filtrate was dried on a bath at a temperature of
70
◦
C to obtain the crude 70% v/v ethanol extract (HYD; yield
12% w/w). Part of the extract (10 g) was kept in a desiccator
until required for use and the remainder (170 g) subjected to al-
kaloidal extraction according to the method described by Shah
and Seth, (2012). Briefly, the 70% v/v ethanol extract (170 g)
was digested with 10% glacial acetic acid (pH=4.9) and basified
with dilute ammonia solution to a final pH of 8.8. The solution
was then partitioned with 2 L of chloroform in successive 200
mL aliquots. The combined chloroform extract was concentrated
and dried to afford a total alkaloidal mixture (ALK) of weight 51
g.
Column fractionation of Alkaloid mixture
The alkaloidal mixture (50 g) was loaded onto a glass col-
umn (60 cm × 3 cm) packed with silica gel (70-230 mesh).
It was then eluted with mixtures of petroleum ether, ethyl ac-
etate and methanol of increasing gradient polarity starting with
100% pet-ether to 100% ethyl acetate and subsequently to 100%
methanol. Fifty-six fractions were collected in 60 mL aliquots
and bulked into six sub-fractions based on their TLC profiles
(coded CF 1-6). Active fraction CF1 (9.5 g) was further col-
umn chromatographed on silica gel (70-230 mesh) using gradi-
ent mixtures of pet ether, ethyl acetate and methanol. Sixty-three
fractions were collected in 20 mL aliquots and bulked into six
sub-fractions which were labelled as Hf1, Hf2, Hf3, Hf4, Hf5
and Hf6.
HPLC separation of compounds in active fraction Hf1
Fraction Hf1 (2.15 g) was subjected to purification by prepar-
ative HPLC [MeOH-H2O + 0.1% HCOOH 98:2, 2 mLmin−1]
to yield compounds Hfa, Hfb and Hfc. High performance liquid
chromatography (HPLC) was performed on a Nexera Shimadzu
LC using a Phenomenex Gemini C18 column (10 × 250 mm,
10 µm particle size) and a chromeleon software system. The
set up consisted of a gynkotek pump equipped with a Dionex
DG-1210 geasser, a Dionex UVD 340S detector and a Dionex
Gina 50 auto-sampler. During the separation, MeOH-H2O sol-
vent system was employed for travelling the RP column with
0.1% formic acid (HCOOH) as buffer. The gradient of 95%
methanol 5 % water to 100 % water was employed in the run.
Flow rate was maintained at 0.62 mL/minute with 25ºC column
temperature.
Experimental
Liquid Chromatography-Mass Spectrometry (LC-MS
LC-MS was employed to check the purity and provide the ex-
act mass and molecular formula of the isolated compounds.
Mass fragmentation (MS2/3) experiments were performed by
collision-induced dissociation (CID) to evaluate the structural
features of compounds based on the fragment information. The
HPLC-MS experiments were carried out on a LTQ Orbitrap
spectrometer (Thermofisher, USA) equipped with a HESI-II
source. The spectrometer is equipped with an Agilent 1200
(Santa Clara, USA) HPLC system consisting of a pump, PDA
detector, column oven (30
◦
C) and an auto sampler. The spec-
trometer was operated with nominal mass resolving power of 60
000 at m/z 400 with a scan rate of I Hz to afford high-accuracy
mass measurements within 2ppm deviation. The HPLC separa-
tions were performed using a Luna C 18 column 10 x 250 mm,
10 µm particle size (Phenomenex, Torrance, USA) with H2O (+
0.1% HCOOH) (A) / MeOH (+ 0.1% HCOOH (B), gradient flow
rate 0.4mL/min. Samples were analysed by using programme
as follows; linear gradient from 5% A to 100% B over 26 min,
100% B isocratic for 5 min, then after the system returned to
its initial condition (95% A, 5 % B) within 0.5 min and was
equilibrated for 4.5 min. The experiments were run in positive
mode under the following parameters: nitrogen sheath gas flow
(arbitrary units) 55, nitrogen auxiliary gas flow (arbitrary units)





C, capillary voltage 20 V and tube lens 100 V.
MS/MS experiments were achieved by collision-induced disso-
ciation (CID, 35 ev) in the Orbitrap mass analyser. The collision
gas used was Argon. The LC-HRMS data was analysed through
the software ThermoXcalibur 2.2 SP1.48 (Thermo Fischer Sci-
entific Inc., USA).
Nuclear Magnetic Resonance Spectroscopy (NMR
One dimensional (1D) NMR spectroscopic techniques includ-
ing 1H and 13C-NMR, together with two-dimensional (2D)
NMR spectroscopic techniques such as correlation spectroscopy
(COSY), hetero-nuclear single quantum correlation (HSQC),
hetero-nuclear multiple bond correlation (HMBC) and nuclear
over-hauser enhancement spectroscopy (NOESY) were used
for the structural elucidation of compounds. 1D NMR, COSY,
HSQC and HMBC afforded the detailed information which was
used to assign the planar structure of the compounds. Solvents
used for NMR analysis were deuterated chloroform CDCl3 and
methanol-d4 (CD3OD) deuteron GmbH, Kastellaun, Germany).
The pure compounds were dissolved and transferred into an
NMR tube (5 x 203 mm) for measurements. NMR spectra
were recorded at 25
◦
C on a Bruker Avance DRX-500 (500
MHz), Varian Unity Inova (500 MHz), Inova spectrometer (600
MHz) or AVANCE III HDX (Bruker BioSpin GmbH; 700 MHz).
Chemical shifts were quoted in parts per million (ppm) relative
to the chemical shift of the internal standard tetramethylsilane (d
0 ppm)
In Vitro studies with S haematobium
Harvesting and maintenance of snails
Naturally infected snails, Bulinus species, were collected from
endemic areas in their natural habitat, Tomefa near Weija in
the Greater Accra Region of Ghana. Identification of Bulinus
species was done according to the method described by Brown
et al [13]. The snails were then transported in well ventilated
aquarium bowl (measuring 27 cm x 12 cm) to the University of
Cape Coast Biomedical Science laboratory, where the work was
done. The water in the aquarium (dechlorinated) was changed
thrice a week to get rid of faeces and foul smell due to feeding.
Snails were allowed five days to acclimatize to the new environ-
ment and fed on lettuce.
Shedding of Cercariae
The procedure described by Tucker et al. [14] with extensive
modification was followed. Snails numbering 10 were placed in
a 10 mL test tube with 2 mL of conditioned water (5 snails per
mL of conditioned water). The tubes were placed on a rack and
then exposed to early morning sunlight (8 am-10 am) for 20 min,
then, placed under desk lamps with fluorescent bulb (60W) light
source for another 40 min. The snails were then removed from
the test tubes with the aid of forceps and placed in conditioned
water temporarily before being returned to the aquarium.
Contents of the test tubes were filtered and then poured into
a petri dish. A Pasteur pipette was used to measure an aliquot
of 1 mL from the petri dish and dispensed into counting wells.
An inverted microscope with objective lens (4×) was used to
estimate the average number of cercariae. Wells with significant
cercariae (18-22) were standardised to obtain an average of 20
cercariae per well.
Preparation of solutions of extracts and isolates
Stock extract and total alkaloidal extract concentration of 1000
µg/mL was prepared and then serially diluted (two fold) us-
ing distilled water to obtain concentrations 500.0 µg/mL, 250.0
µg/mL, 125.0 µg/mL, 62.5 µg/mL, 31.25 µg/mL and 15.625
µg/mL. The isolated compounds Hfa, Hfb and Hfc as well as
the reference drug praziquantel were prepared in a similar way.
Cercariacidal activity
The procedure described by Tekwu et al [15] was followed with
little modification. An estimated freshly shed 20 cercariae, was
placed in each well of the 24-microtiter plate with equal vol-
ume of solution. and the extracts and compounds tested at six
concentrations of 500-15.625 µg/mL (prepared by two fold di-
lution). Survival and mortality was observed at 0, 15, 30, 60, 120
and 180 min. Dead cercaria are non-motile, loose their tail and
sink to the bottom of the well. Percentage viability: dead cercaria
and those alive were observed and calculated at different times
(0, 15, 30, 60, 120 and 180 min). All tests were carried out in
duplicates. Negative controls were prepared with 100% uncon-
ditioned water and 1% DMSO. Praziquantel, at similar concen-
trations, was used as the positive control. IC50 were calculated
at 30 min for all extracts and compounds.
Percentage inhibition
Percentage (%) viability was calculated as = {(K) − (DC)}K ×
100
Where K is total number of cercariae at the beginning of the
experiment
DC is dead cercariae at the specific times (0, 15, 30, 60, 120
and 180 min)
Statistical analysis
Graphpad ® Prism for Windows Version 7.0 (Graphpad Soft-
ware, San Diego, CA, USA, 2017) was used for all statistical
analysis. The concentration-response curves after thirty minutes
of incubation with the plant extracts and compounds was then
used to determine the concentration at which 50% of the cer-
caria lost their viability (i.e. IC50). The IC50s weredetermined
by plotting a nonlinear regression curve (log concentration of
inhibitor verses % viability).
Results
Chromatographic separation of the hydroethanolic stem bark
extract of H. floribunda resulted in the isolation of three com-
pounds. The characterization of compounds was done by High
Resolution Electron Spray Ionisation Mass Spectrometer (HR-
ESIMS) and nuclear magnetic resonance (NMR) analysis.
SciFinder (CAS, a division of the American Chemical Soci-
ety) search of the plant was employed in the identification of
isolated compounds. All data obtained was also compared with
published literature on related compounds.
Identification of compounds
Compound HF1C wasisolated as a yellowcrystal, soluble in
methanol with a melting point of 125-127°C (literature: 126-
127 °C). Its 1H NMR spectrum exhibited three singlets at δ
0.95, 2.23, 2.33 and a doublet at δ 1.07 characteristic of five
methyl groups. An olefinic proton occurred at δ 5.32 and the
aliphatic protons resonated between δ 0.92 and 2.44. The two
protons on C-18 are diastereotopic, one of which appeared at
δ 3.0 (H-18’) and the other at δ 1.89 (H-18”). Furthermore, it
contains a β-CH3 on C-10, trans-fused B and C rings, C and
D rings. The 1H NMR signals of two methyl groups (δ 2.21,
6H, s) suggested the presence of N(CH3)2 group on C-3 (Fig-
ure 1). Signals for all 24 carbon atoms appeared in the 13 C-
NMR spectrum. In NOESY, H-3 (δ 2.25) had correlation with
H-1β (δ 1.99) which also had correlation with H-19 (δ 0.89).
This result confirmed the α-N(CH3)2 group on C-3. The β-CH3
on C-20 was also confirmed by the correlation between H-21 (δ
1.00) and H-16β (δ 1.58). Based on the correlation between H-
22 (δ 2.15) and H-21, a β-CH3 on position 22 was identified,
due to the formation of sp3 type of the nitrogen atom in the E
ring. Based on the NMR data, compound HF-3 was suggested
to be a steroidal alkaloid with an unsaturated bond in the skele-
ton (Figure 1a). It has a double bond equivalent of 6 which is
accounted for by the five rings and one double bond present in
ring B (Figure 1). The molecular formula of HF1C, C24H40N2
determined by HRESI- MS/MS (m/z): 357.3267 [M + H]+; cal-
culated for C24H41N2+: 357.3270. Fragments appearing in the
MS/MS spectra of Hf1C, showed a [M-C2H7N+H] + peak at
m/z 312.269, then [-C2H6] + peak at m/z 206.190, and [-C2H3]
+peak at m/z 283.23 and a fragment at m/z 268.229. The NMR
and mass spectra data agreed with that published for cones-
sine [11] which has been reported in the bark of this plant. [16]
It has three six-membered rings of which ring B adopts a half-
chair-like conformation while rings A and C forms a chair-like
one. The cyclopentane ring D shows a half-chair conformation
and the methylpyrrolidine ring E adopts an envelope conforma-
tion. The dimethylamino substituent in ring A is equatorially ori-
ented. [17]
Similarly, compound HF1B was isolated as a yellow amor-
phous powder soluble in methanol. The 1H NMR spectrum ex-
hibited two tertiary methyl groups at δ 2.29 (N-Me) and 1.19
(H-19) and a secondary methyl group at δ 1.08 (d, J=6.36
Hz, H-21)(Figure 1b). The chemical shifts of N-Me and H-21
were comparable with those of conessine derivatives. [18] The
presence of a conjugated ketone was suggested by the three
deshielded olefinic protons at δ 7.03 (d, J=10.14 Hz), δ 6.21
(dd, J= 10.14, 1.91Hz) and δ 6.06 (t, J = 1.91 Hz) which were
assigned to protons H-l, H-2 and H-4, respectively (Figure 1b).
From the mass spectrum of C22H31NO (HRMS, [M+1] 326.248)
calculated 326.49, fragments appearing in the MS/MS spectra of
Hf1b, showed a [M-Me] + peak at m/z 311.225), [M-C2H6]+,
peak at m/z 296.201, [M-Me, CO]+,peak at m/z 283.23 and a
fragment at m/z 268.229.
HF1B has a pentacyclic steroidal nucleus (Figure 1b); the ring
junctions share the same stereochemistry reported for steroidal
alkaloids. In addition, the number of double bond equivalents
8 is accounted for by the 5 rings and 3 double bonds. These
data characterized HF1B as holadienine, which was corrobo-
rated by 13C NMR and HMBC experiments as well as various
fragments in the mass spectrum, characteristic of this type of
compound. [19] Holadienine was previously isolated from the
stem bark of H. pubescens. [20]
Compound HF1A was also isolated as a white amorphous
powder soluble in chloroform. The 1H and 13C NMR spectra
was consistent with that of holadienine (compound HF1B) ex-
cept for the presence of a hydroxyl group at C-11 and C=N group
at position 18 (Figure 1c). The presence of the hydroxyl group
resulted in C-11 of HF1A resonating more downfield at δ 68.91
compared to δ 25.1 in holadienine. Similarly, the double bond at
C-18 (of HF1A) resulted in the downfield signal of δ 168.37 with
that of holonamine resonating at δ 68.91 (no double bond). Sig-
nals belonging to all the 21 carbon resonances were accounted
for with the molecular mass established as C21H27NO2 (HRMS,
[M+1] 326.20) calculated 326.2120. HF1A has a pentacyclic
steroidal nucleus; the ring junctions share the same stereochem-
istry reported for this class of compounds. It has five rings and
four double bonds in the structure accounting for the 9 double
bond equivalents. The 13C NMR and complete 1HNMR spec-
tral assignments have also been made. These data characterized
HF1A as holonamine which agreed with that published for this
compound. [11]
Anti cercarial activity
The present study focussed on the anti-cercarial activity of ex-
tracts (total hydroethanolic extract and its alkaloidal fraction)
and steroidal alkaloids isolated from H. floribunda on S. haema-
tobium cercariae. The extracts showed concentration and time-
dependent cercariacidal activity whereas all the normal control
cercaria survived throughout the entire duration of incubation.
Praziquantel, the reference drug used in the management of adult
worms of Schistosoma, could not achieve 0% viability at all the
tested concentrations throughout the 180 minutes of the test. Its
maximum effect was 50% mortality of cercariae which occurred
at its highest concentration of 500 µg/mL (Figure 2a).
The alkaloidal fraction (ALK) showed 100% mortality at
all concentrations within an hour (Figure 2b). This was sim-
ilar to that of the crude 70% v/v ethanol extract (HYD) ex-
cept that its lowest concentration of 15.65 µg/mL could not
achieve 100% mortality of the cercaria (Figure 2c). Time-course
curves of the isolated compounds holonamine (Hf1A), holadie-
nine (Hf1B) and conessine (Hf1C) showed a similar concentra-
tion and time-dependent effect except that the extracts showed
higher cercariacidal effect at all concentrations than the com-
pounds. The least effective cercaricidal agents among the three
compounds was Holadienine (Hf1B) as its highest concentration
of 500 µg/mL was able to achieve 100% mortality of the cer-
caria at the 180 min of incubation (Figure 3b). Conessine (Hf1C)
showed a remarkable cercariacidal effect as concentrations up to
62.50 µg/mL showed 100% mortality of the cercaria within just
15 min of incubation (Figure 3c). On the other hand, concentra-
tions up to 31.25 µg/mL of holonamine (Hf1A) achieved 100%
cercariacidal effect within 120 min of incubation (Figure 3a)
Concentration-response curves (Figure 4) were used to es-
tablish their potencies in terms of the IC50 (Table 1). The total
crude extract (HYD) exhibited the highest cercaricidal potency
with an IC50 value of 20.09±1.11 µg/mL which was about 34
times more potent than the reference drug, Praziquantel. This
was followed by the conessine, total alkaloidal fraction, holon-
amine, and holadienine (Table 1).
Figure 1 Structures of conessine, holadienine and holonamine showing key HMBC correlations
Table 1 Anti-cercarial activity of extracts and compounds of H. floribunda
Extracts/compounds IC50 (µg/mL) Negative control % mortality
Praziquantel (PZQ) 695.50±1.12 0
Total crude (HYD) 20.09±1.11 0
Alkaloid extract (ALK) 53.20±1.33 0
Holonamine (HF1A) 53.24±1.28 0
Holadienine (HF1B) 470.80±1.00 0
Conessine (HF1C) 33.28±1.04 0
Discussion
Schistosomiasis, one of the neglected tropical diseases, is on
record to have debilitating effect on about 20 million suffer-
ers [1] with 218 million people requiring prophylaxis in endemic
areas, to stay off the disease. [21] The rural poor in Africa, es-
pecially Sub-Saharan Africa, are the most affected. The drug
of choice, praziquantel, has enjoyed a monopoly of use against
adult schistosomes for over three decades. However, with the
efficacy of antibiotics on the wane due to microbial resistance,
legitimate concerns over a similar fate for praziquantel has been
echoed and thus the search for alternative agents is an important
research agenda. A call for an integrated approach to sustain-
able management of the disease involving mass chemotherapy,
behavioral changes towards risk factors, control of snails and
larval forms of the parasite has been made and rightly so.
In this study, the total hydroethanolic extract (HYD), its alka-
loidal fraction as well as isolated steroidal alkaloids were tested
in vitro against cercariae of S. haematobium using praziquantel
as reference drug. HYD showed higher cercaricidal activity than
its alkaloidal fraction and compounds (Table 1). The activity of
the extract was about 34 times higher than that of praziquantel
used as reference but only three times more potent than its al-
kaloidal fraction (Table 1). Thus purification resulted in loss of
anti-cercarial activity.
Conventional agents or drugs for the control of cercaria are
not widespread. A number of plant materials, such as Balanites
aegyptiaca, have been used to control snails and cercaria. Thus
the high cercaricidal activity exhibited by H. floribunda extract
affords a novel treatment option to be considered in an integrated
control of schistosomiasis involving water treatment in endemic
Figure 2 Time dependent percentage viability of Schistosoma haematobium cercaria exposed to a. Praziquantel (PZQ) b. crude extract (HYD) c.
crude alkaloid extract (ALK) of H. floribunda
areas. Praziquantel is on record to be very active against adult
schistosome worms, but inefficient against the younger stages
of schistosomes such as cercariae, schistosomula, preadults, and
juvenile adults. [15] This reflected in the low activity recorded
in this study. As a result, repetition of treatment is sometimes
necessary to kill those parasites that have since matured.
The alkaloidal fraction and its isolates also showed consid-
erable activity. The alkaloid Conessine (Hf1C) showed anticer-
carial activity comparable to the hydroethanolic extract (Table
1). This was followed by holonamine (Hf1A) and holadienine
(Hf1B). Holonamine, like the other compounds, exhibited a time
dependent activity in relation to the percentage viability but de-
viated from the norm with regards to its linear relationship in
terms of the concentrations (Figure 3a). Thus, alkaloids from H.
floribunda may be responsible for it anti-cercarial activity. This
is the first report of the cercaricidal activity of H. floribunda ex-
tracts and its alkaloids. Alkaloids from Holarrhena species have
shown diverse biological activities including considerable anti-
trypanosomal [11], antimicrobial and cholinesterase inhibitory
activities. [22] H. floribunda, used by traditional healers in Benin
to treat buruli ulcer, was reported to exhibit significant in vitro
antimycobacterial activities. [12] The steroidal alkaloids ho-
laphyllinol, holamine, holaphyllamine and holadysamine were
found to be responsible for the Mycobacterium ulcerans in-
hibitory effect with the latter exhibiting the highest activity. This
study and previous work on Holarrhena species bring the genus
into the spotlight as clear candidates in the search for novel drugs
to mitigate microbes and parasites responsible for some of the
neglected tropical diseases.
The anticercarial activity of the compounds conessine, holon-
amine and holadienine was lower than that of the total crude
extract, suggesting a possible synergistic action of the steroidal
alkaloids. The three compounds have a similar steroidal frame-
work but the absence of the α-N(CH3)2 at C-3 in holonamine
and holadienine appear to have resulted in the higher activity
of conessine than the others. Conessine, isolated from the bark
of Holarrhena antidysentrica exhibited substantial anti-malarial
activity. [23] In another study, conessine showed antimicrobial
activity against four Bacillus species. [24]
This research has highlighted the potential of hydroethano-
lic extract of H. floribunda or its active metabolite conessine
for consideration in the new global strategy for the manage-
Figure 3 Time dependent percentage viability of Schistosoma haematobium cercaria exposed to compounds a. holonamine (Hf1A) b.
Holadienine (Hf1B) and c. Conessine (Hf1C) isolated from H. floribunda
Figure 4 Concentration-response curves on the %viability of S. haematobium cercaria exposed to praziquantel (PZQ), crude extract (HYD) and
alkaloid extract (ALK) of H. floribunda as well as holonamine (Hf1A), Holadienine (Hf1B) and Conessine (Hf1C) isolated from the plant.
ment of schistosomiasis which focuses on the two main trans-
mission pathways in the schistosome life cycle: parasites’ path 
from humans to snails, and their path from snails to humans. 
Treatment with PZQ acts only on the transmission pathway from 
humans to snails and only for as long as treatment is given. Some 
treatment approaches have harnessed the efficacy of Artemether 
(ART) (and other artemisinin derivatives), found to be effective 
against cercaria and juvenile schistosomes during the first 21 
days of infection in both animals and humans. [25] Thus the 
combination of PZQ-ART is expected to improve cure rates, re-
ducing the reservoir pool of infected individuals needed to halt 
transmission. [26] This is notably helpful due to the inability of 
PZQ to kill migrating schistosomula and the early stages of the 
disease. [27]
A multifaceted integrated approach complementing PZQ 
treatment with snail and cercaria control in water should be 
considered in which case H. floribunda extracts and its alkaloids 
are important leads.
Conclusion
The present study has shown that H. floribunda s tem bark ex-
tract and steroidal alkaloids demonstrates anti-cercarial activity, 
in vitro, against cercariae of S. haematobium. This gives cre-
dence to the traditional use of the plant as an anti-parasitic agent.
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